CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EXEC VP, CFO AND CBO sold 40,000 shares at $11.06 ($442,400)
- 4 Open-market sale EVP, DEVELOPMENT AND CMO sold 58,584 shares at $7.69 ($450,365)
- 4 Open-market sale CEO sold 40,000 shares at $7.68 ($307,044)
- 4 Open-market sale VP AND GC sold 13,163 shares at $8.00 ($105,304)
- 4 Open-market sale EXEC VP, CFO AND CBO sold 40,000 shares at $7.68 ($307,084)
- 4 Option exercise Director acquired 4,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Gift CEO gave 7,500 shares (gift)
- 4 Option exercise EXEC VP, CFO AND CBO acquired 12,000 shares (option exercise)
- 4 Option exercise Director acquired 4,500 shares (option exercise)
- 4 Option exercise Director acquired 4,500 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale VP AND GC sold 20,602 shares at an average $6.06 ($124,845)
- 4 Open-market sale EXEC VP, CFO AND CBO sold 40,000 shares at an average $6.02 ($240,633)
- 4 Option exercise EXEC VP, CFO AND CBO acquired 7,500 shares (option exercise)
- 4 Gift CEO gave 23,333 shares (gift)
Page 25 of 35 · 686 filings